We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
4026
Zebra Technologies
ZBRA
$17.5B
-302
Closed -$25K
ZEUS
4027
DELISTED
Olympic Steel
ZEUS
-485
Closed -$12K
ZG icon
4028
Zillow
ZG
$8.44B
-2,494
Closed -$95K
ZTO icon
4029
ZTO Express
ZTO
$18B
-100
Closed -$1K
ZTR
4030
Virtus Total Return Fund
ZTR
$338M
-1,256
Closed -$15K
RPT
4031
Rithm Property Trust
RPT
$95.4M
-286
Closed -$22K
ATYR
4032
aTyr Pharma
ATYR
$51.9M
-80
Closed -$2K
ONIT
4033
Onity Group
ONIT
$321M
-271
Closed -$22K
SMC
4034
Summit Midstream
SMC
$417M
-39
Closed -$14.1K
UCB
4035
United Community Banks
UCB
$4.32B
-2,465
Closed -$73K
OMCC
4036
DELISTED
Old Market Capital Corp
OMCC
-107
Closed -$1K
HURA
4037
TuHURA Biosciences
HURA
$133M
0
-$1K
AIFU
4038
AIFU Inc
AIFU
$216M
0
IRD
4039
Opus Genetics
IRD
$312M
-63
Closed -$4K
GRCE
4040
Grace Therapeutics
GRCE
$34.8M
$0 ﹤0.01%
5
-1
-17% -$61
MAGN
4041
Magnera Corp
MAGN
$482M
-45
Closed -$14K
SUNE
4042
SUNation Energy
SUNE
$10.8M
0
-$5K
ENFY
4043
DELISTED
Enlightify Inc
ENFY
-132
Closed -$2K
MTVA
4044
MetaVia Inc
MTVA
$7.69M
0
-$3K
JBTM
4045
JBT Marel
JBTM
$6.35B
-1,929
Closed -$166K
XYZ
4046
Block Inc
XYZ
$50.1B
-1,236
Closed -$17K
QVCGA
4047
DELISTED
QVC Group Inc Series A
QVCGA
-85
Closed -$82K
NAGE
4048
Niagen Bioscience
NAGE
$234M
-572
Closed -$2K
VIVS
4049
VivoSim Labs
VIVS
$1.27M
-43
Closed -$35K
EVBN
4050
DELISTED
Evans Bancorp Inc
EVBN
-29
Closed -$1K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.